ArticleBMC public health2025
Predicting metabolic syndrome by lipid accumulation product, visceral adiposity index and body roundness index in Brazilian rural workers.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Association and predictive value of the visceral adiposity index in diabetic kidney disease: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Association between obstructive sleep apnea syndrome and metabolic syndrome: a severity-stratified meta-analysis.Frontiers in medicine · 2026Pooled it
- Knee Osteoarthritis and Metabolic Disorders: Practical Aspects from Primary Healthcare.Journal of clinical medicine · 2026Article
- Cardiometabolic index predicts postoperative atrial fibrillation after isolated CABG: ROC-based comparison with BMI and visceral adiposity indices.Biomolecules & biomedicine · 2026Article
- Gender-Specific Predictive Utility of Twelve Anthropometric Indices for Metabolic Syndrome in Chinese Lahu Adults with Dyslipidemia.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
- Central Adiposity Assessed with Body Roundness Index and Mortality: The Seguimiento Universidad de Navarra Prospective Cohort.Geriatrics (Basel, Switzerland) · 2025Article
- The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic Disorders.Nutrients · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAnthropometric indicators, such as the Lipid Accumulation Product (LAP), the Visceral Adiposity Index (VAI), and the Body Roundness Index (BRI), could be valuable tools for identifying metabolic syndrome (MS) in rural populations because of their simplicity, low cost, and ability to identify central obesity and related metabolic risks where access to healthcare is limited. This study aimed to evaluate the predictive capacity of three anthropometric indices for identifying MS in a representative sample of rural workers in Espírito Santo, Brazil.
methodsA cross-sectional analysis was conducted, and the diagnostic performance of these indices was assessed via ROC curves under the NCEP and IDF criteria for MS. The study involved 806 participants, aged 18-59 years, and the data collection included anthropometric measurements, biochemical tests, and blood pressure assessments.
resultsThe results showed that LAP had the highest discriminatory capacity for MS under both diagnostic criteria, with AUCs of 0.803 (NCEP) and 0.885 (IDF), followed by BRI and VAI. The cutoff points identified for LAP were 33.84 (NCEP) and 26.80 (IDF), with high sensitivity and specificity. The BRI also demonstrated strong predictive power with AUC values above 0.7, whereas the VAI had the lowest AUC among the indices but remained a useful predictor. The correlations between the indices and MS components highlighted significant relationships, especially between LAP and triglycerides (r = 0.830).
conclusionsThis is the first study to determine cutoff points for these indices in a rural Brazilian population, suggesting that LAP and BRI are reliable tools for MS screening. The low cost of these methods could aid in improving healthcare accessibility and prevention strategies in rural areas with limited resources. Future research is recommended to validate these findings in other populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.